Eylea Granted Authorization in Europe for use as Macular Degeneration Treatment
(PreserveMacForte.com) Bayer HealthCare's Eylea (aflibercept “VEGF trap-eye”) intravitreal injection drug has been granted authorization in Europe to be used as a treatment for the wet version of age-related macular degeneration